The present investigation is aimed to prepare the sustained release beads of carbamazepine using different proportions of talc and sodium alginate for sustained delivery of carbamazepine. The proposed beads were formulated using the inotropic gellan method. The drug to talc to polymer ratio in optimized batch S 2 was kept at 1 : 0.5 : 0.3. The obtained beads were characterized for its particle size distribution, percent drug content, mean diameter and crushing strength, thermal analysis (DSC), crystallinity (PXRD), surface morphology (SEM), and in vitro drug release. The prepared beads were found to be optimal in terms of particle size and entrapment efficacy. There were no compatibility issues and the crystallinity of drug was found to be reduced in prepared microspheres, which were confirmed by DSC and PXRD studies. The time to release 70% of drug from all batches of beads were in the range of 0.5 -3.0 h, which could be used to prevent the formation of carbamazepine dehydrate form (CBD) having one third solubility of carbamazepine and high extent of drug release. The drug was sustained for optimized batch S 2 was 5 hour. Further investigations are required to reduce the amount of polymer in microspheres that can provide maximum drug loading and acceptable dosage form.
Introduction
Almost 60% of drug molecule available in market possesses either solubility or permeability related pharmacokinetic problems. The most important and common problem associated with the oral dosage form is low aqueous solubility of drug not only in dissolution media but also in gastrointestinal fluid. Many oral controlled drug release systems have been developed to improve drug bioavailability and release the drug for prolonged period of time. The main objective of such a drug delivery system is to control the release profile of the drug and also retain the drug in gastric environment. Moreover, the drug must be released from the delivery system in the absorption window, where the drug gets maximum absorption. Most of the drug delivery carrier systems such as microspheres and nanoparticles have been developed to improve the bioavailability and to enhance the pharmacokinetic properties, which can lead to improve the patient compliance.
*Corresponding Author:
vikramsinh.deshmukh@yahoo.com Microspheres are ideal carriers for delivery of the drug in both oral and parental routes of administration. Microspheres have been developed for not only sustaining the drug release profile but have also been used to enhance the extent of drug release. Carbamazepine (CBZ), an anti-epileptic drug is used in the treatment of epilepsy, trigeminal neuralgia, and bipolar disorders. Carbamazepine is used as first line monotherapy for seizures in elderly patients. The major advantage of carbamazepine include proven efficacy and less cost. The conventional CBZ tablets yield peak plasma concentration varying from 4 to 32 h 1 . Irregular and delayed absorption of CBZ is attributed to slow dissolution rate. Dissolution enhancement of CBZ can result in increase in the rate and extent of absorption and hence bioavailability. Several attempts using water-soluble carriers have been made to prepare different formulation of CBZ solid dosage forms with improved dissolution properties. Variation in drug dissolution is also due to the availability of various physical forms of CBZ. CBZ has at least four different polymorphs (I, II, III, and IV) and a dihydrate form. Dihydrate of CBZ has one-third solubility compared to its anhydrous form. The conversion of CBZ to carbamazepine dihydrate (CBD) in the gastrointestinal tract is one of the major rate-limiting steps in bioavailability of oral dosage forms. The burst release of CBZ from immediate release (IR) dosage forms lead to supersaturation of the drug in GIT and facilitates formation of CBD and hence offers poor dissolution rate and bioavailability.
1 The alternative way to reduce the super-saturation and re-crystallization of CBZ in stomach is formulating it as sustained release dosage forms that prevent the burst release, supersaturation, and CBD formation. CBZ loaded microspheres were synthesized and evaluated for their pharmaceutical applicability in both oral and non-oral routes of administration. Present investigation is to develop sustained release microspheres loaded with carbamazepine with aim to improve the bioavailability, the pharmacokinetic properties and the patient compliance. 
Materials and Methods

Materials
Preparation of beads
Beads were prepared by using inotropic gelation method which is based on the ability of polyelectrolyte to crosslink in presence of counter ions to form hydrogels. Carbamazepine (1g) was dissolved in 10 ml ethyl alcohol at 50 o C . Talc (0.5g, 1.5g, 2.5g) was added with stirring. Uniform solution of Sodium alginate (0.2g, 0.3g, 0.4g) was prepared separately in 14 ml distilled water with continuously stirring. The alginate solution was added to carbamazepine and talc dispersion slowly with vigorous stirring until a uniformed dispersion was obtained. Finally, the resultant homogeneous bubble free solution was dropped using a disposable syringe (No. 18) into 150 ml of calcium chloride solution (0.02%w/v) at 150 rpm for 15 min. The beads were collected after filtration and washed with distilled water. Beads were dried at room temperature. All batches were prepared in triplicate. The 3 2 factorial design was used to study the effect of talc and sodium alginate on characteristic of beads.
Pharmaceutical characterization
Drug content
Accurately weighed quantity of the beads (10 mg) was dissolve in 10 ml ethanol and sonicated for 15 minute. Solution was filtered through 0.45um filter. Pipette out 1ml of solution and dilute up to 10 ml with 1% Sodium lauryl sulphate in distilled water. The drug content was determined at 285nm by UV-VIS Double Beam Spectrophotometer (Jasco V500, Japan.) Particle size analysis Particle size of 50 beads was measured with digital microscopy, Inverted Microscope (Nikon Eclipse E 600 Pol Japan). The prepared microspheres were subjected for particle size analysis. Microspheres were suspended in liquid paraffin and particle size was measured.
Crushing strength
Crushing Strength of beads was determined by mercury load cell method 15 using 20ml hypodermic glass syringe. Beads were randomly sampled and subjected to crushing strength determination.
Thermal analysis
Differential scanning calorimetric (DSC) analyses of the CBZ and microspheres were carried out by using a differential scanning calorimeter equipped with computer analyzer (Mettler Toledo 821e, Switzerland). Samples (of 3-7 mg) were heated in a nitrogen atmosphere on an aluminum pan at a heating rate of 10ºC/min over the temperature range of 60-200 o C.
Powder X-ray diffraction
Powder X-ray diffraction (PXRD) patterns were traced employing an X-ray diffractometer (Philips PW 1729 Almelo, Netherland.)The samples were analyzed over 2è range of 5.010-39.990 o with scanning step size of 0.020 o (2è) and scan step time of 1 s. The crystalline properties of carbamazepine, talc, alginate beads were studied by X-ray powder diffraction (XRPD) using an X-ray diffractometer (PW 1729; Philips, Almelo, Netherlands). The samples were irradiated with monochromatized Cu Kα radiation (1.542 Å) and analyzed at 2θ between 2° and 60°. The voltage and current used were 40 kV and 40mA, respectively. The range and the chart speed were 2 × 104cps and 10 mm/2, respectively.
Scanning electron microscopy
The surface topography of the beads were examined using optical microcopy and scanning electron microscope (Cambridge Stereoscan 120 UK) Samples were coated with gold film under vacuum using a sputter coater (SPI Sputter™ Coating Unit, SPI Supplies, Division of Structure Probe, Inc., PA, and USA) and then investigated.
In vitro dissolution studies
The dissolution studies were performed using USP 24 Type II dissolution test apparatus (Electrolab TDT-06P Mumbai, India), The carbamazepine loaded alginate talc beads (500 mg) sample equivalent to 200 mg of carbamazepine placed in the dissolution vessel containing 900ml of 1% SLS in distilled water as a dissolution medium at 37ºC ± 0.5ºC and stirred at 50 rpm. Periodically, samples were collected and the volume of dissolution medium was kept constant throughout the run by replacing the removed samples with an equivalent volume of fresh dissolution medium. After filtration through Whatman filter paper no 41 (Whatman, Middlesex, UK) concentration of carbamazepine was determined by using UV-Spectrophotometer at 285 nm. Analysis of data was done using PCP Disso software (V3, Poona College of Pharmacy, Pune, India). The 3 2 factorial design was used to study the effect of talc and sodium alginate on Q120 (Cumulative percentage release in 120 min) and t 70 (Time required to release 70% drug). In vitro Dissolution study percent drug release of Carbamazepine loaded talc alginate beads were compared with marketed product (Tegrital CR tablet).
Results and Discussion
Preparation of beads Beads were prepared by the inotropic gelation method were found to be spherical in nature. This technique has been used for encapsulation of drug in sodium alginates .Gelation occurs by cross-linking of the uronic acids with divalent cations, such as Ca2+.The hydrogel beads are produced by dropping a drug-loaded polymeric solution into the aqueous solution of polyvalent cations. Sodium alginate was used as a matrix-forming agent for preparation of microspheres .During the preformulation studies, various operation temperatures such as 25ºC, 30ºC, 40ºC, and 50ºC were tried to get optimal spherical nature. The operation temperature of 50ºC was found to be optimal. Homogenization speed was considered as critical parameter in the preparation of microspheres. Homogenization speed of 150 rpm was found to be optimal for preparation of microspheres. The present study revealed that the inotropic gelation method was found to be suitable for preparation of carbamazepine loaded alginatetalc beads to prepare sustained release formulation.
Particle size analysis
The results obtained from particle size analysis revealed that mean diameters of synthesized beads were in the range of 1.5 to1.9 mm.
Percentage drug content
The drug content mainly influenced by the concentration of talc rather than alginate concentration.
3 The relation observed in the drug content with talc concentration. Adsorption of drug on the surface of talc due to hydrophobic interaction.
Here increase in concentration of talc decrease in drug content which may be due to hydrophilichydrophilic interaction of alginates repeal Carbamazepine, thus reduce percentage drug content. 
Mean diameter
Concentration of talc and alginate both show positive influence on mean diameter of beads. Increase in concentration of talc and alginate increase in viscosity of dispersion. Thus increase the diameter of beads. 5 This may be due to dry fine talc particles provides more surface area in turn allows formation of large number of interparticular bridges. Secondly hydrophobic interaction between talc and drug seems to be more influence than the hydrophobic hydrophilic interaction with alginate. The strong hydrophobic interaction between talcdrug may squeeze out the alginate on the surface.
6.
The effect of alginate on the diameter can be explained on the basis of available cohesive layer of polymer on the surface of beads. Crushing strength Concentration of talc and alginate both showed positive influence on crushing strength, high concentration of talc shows slower breakdown means high crushing strength. 6 The crushing strength of beads is determined by various interparticular forces. The liquid bridges in wet beads between insoluble solid particles of talc and or drugs are influence on agglomeration of particles during the formation of beads. The strength of dry beads depends on formation of solid bridges due to drying of alginate solution that hold insoluble partical strongly. The formation of interparticular bridges also depends on the surface area provided by the particles and beads have limited increase in crushing strength. 
Thermal analysis
Thermal behaviors of CBZ, polymers and microspheres were characterized by differential thermal calorimetric methods. (Figure 4) shows the DSC thermogram of drug, polymers, and formulation. Thermogram of pure carbamazepine show melting endothermic peak at 173.51ºC which was suppressed or shifted in presence of talc and alginate.DSC thermogram of sodium alginate show endotherm at 105.2ºC attributed to the melting point of the alginate.
Crystalline state evaluation
The P XRD diffractogram of pure carbamazepine, blank alginate talc beads and carbamazepine loaded alginate talc beads were showed in Fig 1.5 The carbamazepine showed numerous distinctive peaks that indicated a high crystallinity nature. The high intensity peak of showed in plane alginate talc bead which may be due to platy nature of talc . The PXRD peaks of crystalline carbamazepine in drug loaded alginate talc beads were similar with low intensity to those in pure drug indicating decrease in the crystalline nature of drug. Scanning electron microscopy SEM photography and typical surface morphology of plane alginate talc beads, Carbamazepine loaded alginate beads and Carbamazepine loaded alginatetalc beads were shown in figure 6 . The blank talc alginate beads 6 D were less spherical and white in appearance shows more rough surface. Prepared beads (6 B and 6 C) have excellent flow properties and hence there was no need of hydrophobic lubricants and glidants for further pharmaceutical dosage form development. The solid state SEM analysis also revealed that the prepared microspheres were found to devoid of aggregation particles and hence posses negligible surface charges, and hence the beads were found to be physical y stable.
In vitro dissolution studies
The drug release of Carbamazepine loaded alginate talc beads was carried out in 1% SLS in distilled water. The drug release patterns were shown in Table 3 . The initial burst releases (14-21%) within the first 15 min were observed in all the batches which may be due to presence of drug on the surface of beads as well as faster penetration of dissolution medium. The 3 2 factorial design was used to study the effect of talc and sodium alginate (independent variables) on Q 120min (Cumulative percentage release in 120 min) and t 70% (Time required for 70% release) (dependent variables). The response surfaces of the obtained result were also plotted ( Fig7 & Fig. 8 ).
The data analysis of values obtained from various batches for Q 120min and t 70% was subjected to multiple regression analysis using PCP Disso software (Table  4 & Fig 5) . The equation fitted was,
Where Y: measured response; X: levels of factors; β: coefficient computed from the responses of the formulations.
Concentration of talc and alginate showed negative influence on drug release at 120 min. Increase in concentration of talc and alginate increases the time required to release the drug which may be due to combined effect of different proportions of hydrophobic talc and time required for swelling and gelling of alginate. The predominant effect of talc as compared to alginate can be explained on the basis of hydrophobic nature of talc with potential to repeal water influx into beads hence retard drug release 4 and drug-talc hydrophobic interaction. It is in accordance with the drug content and crushing strength of beads. The cumulative percent drug release of S1, S2, S3 batches and Marketed product was studied. The optimized batch (S2) showed similar drug release profile as compared to marketed formulation.
Stability Studies
Accelerated Stability Studies of optimized batch of beads (S2) was done as per ICH Guidelines at 40±2 °C / 75±5% RH for two months. It was observed that after two month no significant change in percent drug content and percent release of beads was observed. It was similar to that at time zero and no significant changes during the whole period of investigation. (Table 1 .5 and figure 9 ).
Conclusion
The present investigation was aimed to prepare sustained release for delivery of CBZ that will provide sustained drug release .The inotrpic gelation method was utilized in the preparation of CBZ beads. The beads prepared by this method were found to be more uniform in size and provided better-controlled release profile of CBZ that could prevent the re-crystallization and carbamazepine dehydrate (CBD) formation. Selected excipients were compatible with drug that was characterized by DSC studies. CBZ was found to be partly crystalline in state and/or entrapped in the beads system, which was confirmed by PXRD studies. 
